CD8A and neoplasm: We found that in mice treated with the combination of CD103+CD8+ TRM cells and PD‐1 inhibitor, tumour growth was significantly inhibited, thereby confirming that CD103+CD8+ TRM cells can potentiate the therapeutic effects of immunotherapy (Figure 7J,K).